| 5-HT | 5-hydroxytryptamine |
| ACC | Anterior cingulate cortex |
| aCSF | Artificial cerebrospinal fluid |
| AMPA | Alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid |
| AP | Action potential |
| APV | 2-amino-5-phosphonovalerate |
| ATP | Adenosine triphosphate |
| BAPTA | 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid |
| CCh | Carbachol |
| CNQX | 6-cyano-7-nitroquinoxaline-2,3-dione |
| EGTA | Ethylene glycol tetraacetic acid |
| fAHP | Fast afterhyperpolarization |
| GABA | Gamma-aminobutyric acid |
| GTP | Guanosine triphosphate |
| HEPES | 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid |
| L-ADP | Long-lasting delayed afterdepolarization |
| L-AHP | Long-lasting delayed afterhyperpolarization |
| LY367385 | An inhibitor of metabolic glutamate receptor mGluR1 |
| ML218 | A T-type Ca2+ channel inhibitor |
| MPEP | 2-methyl-6-(phenylethynyl) pyridine |
| NGFCs | Neurogliaform cells |
| NMDA | N-methyl-D-aspartate |
| NMDG | N-methyl-D-glucamine |
| PBS | Phosphate-buffered saline |
| PFA | Paraformaldehyde |
| PFC | Prefrontal cortex |
| RMP | Resting membrane potential |
| SEM | Standard error of the mean |
| SLM | Stratum lacunosum-moleculare |